Coagulation Analyzer Market Report 2023: Industry Technology (Optical Technology, Mechanical Technology, Electrochemical Technology) and Forecast By 2028

PRESS RELEASE

Published April 12, 2023

What is the Market Size of Coagulation Analyzer ? :

IMARC Group’s latest report, titled “Coagulation Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, The global coagulation analyzer market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.7% during 2023-2028.

What is Coagulation Analyzer ? :

A coagulation analyzer is a medical instrument that measures the clotting ability of a patient's blood. It is commonly used in clinical laboratories to help diagnose bleeding disorders and monitor the effectiveness of anticoagulant therapy. It performs a variety of tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, D-dimer, and platelet aggregation. PT measures the time it takes for blood to clot after a substance is added to the sample, while aPTT measures the time it takes for a clot to form in a specific chemical environment.

Fibrinogen is a protein that plays a key role in blood clotting, and D-dimer is a marker of blood clot breakdown. Platelet aggregation measures how well platelets clump together to form a clot. It is designed to be accurate, reliable, and easy to use, with results that can be delivered quickly to help physicians make informed decisions about patient care. It is an essential tool in the management of thrombotic and hemorrhagic disorders and is used in a wide range of clinical settings, from hospitals and clinics to research laboratories.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/coagulation-analyzer-market/requestsample

Coagulation Analyzer Market Demand and Development:

The escalating healthcare expenditure majorly drives the global market. This can be supported by the growing prevalence of coagulation-related diseases and disorders, such as deep vein thrombosis, pulmonary embolism, stroke, and thromboembolism. Along with this, the increasing awareness of the importance of coagulation tests for the diagnosis and treatment of these disorders is driving the market. In addition, the rising adoption of coagulation analyzers in research laboratories and the development of innovative products, such as automated and integrated coagulation analyzers, are significantly supporting the market.

Apart from this, the accelerating number of clinical trials and research activities related to coagulation disorders are also contributing to the market. Moreover, the increasing penetration of laboratory automation and the need for advanced coagulation analyzers are creating a positive market outlook. Some of the other factors driving the market include the rising demand for point-of-care testing and the growing number of trauma cases.

Competitive Landscape with Key Players:

Abbott Laboratories
Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
Nihon Kohden
Sysmex Corporation
Siemens Healthineers Company
Thermo Fisher Scientific Inc
Helena Laboratories Corporation
DIAGNOSTICA STAGO
Instrumentation Laboratory Company

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/coagulation-analyzer-market

Key Market Segmentation:

Breakup by Testing Type:

Prothrombin Time Testing (PT)
Fibrinogen Testing
Activated Partial Thromboplastin Time Testing (APTT)
Activated Clotting Time Testing (ACT)
D-Dimer Testing
Platelet Function Testing
Anti-Factor Xa Testing
Others

Breakup by Product Type:

Instruments/Analyzers

Automated Analyzers
Semi-Automated Analyzers
Manual Analyzers

Reagents
Consumables
Others

Breakup by Technology Type:

Optical Technology
Mechanical Technology
Electrochemical Technology
Others

Breakup by End User:

Clinical Laboratories
Diagnostic Centers
Hospitals
Others

Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

Market Performance (2017-2022)
Market Outlook (2023-2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Research Reports:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800